Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Am Heart J. 2023 Jun 12;264:153–162. doi: 10.1016/j.ahj.2023.06.005

Table 1.

Characteristics of 67 Children with Hypertrophic Cardiomyopathy in a Study to Determine the Prevalence of Myocardial Fibrosis with Late Gadolinium-Enhancement

Patient Characteristic Values
Age at Enrollment, median (IQR), years 13.8 (11.1 to 15.3)
Age at Diagnosis, median (IQR), years 12.1 (8.8 to 14.3)
Males, N (%) 52 (78)
Ethnicity, N (%)
 Not Hispanic 63 (94)
 Hispanic 4 (6)
Race, N (%)
 White 55 (82)
 Black or African American 6 (9)
 American Indian or Alaskan Native 1 (1.5)
 Asian 1 (1.5)
 Multi-racial 3 (4.5)
 Unknown 1 (1.5)
Cardiac medications at enrollment, N (%)
 Beta-Blocker 38 (57)
 Calcium-Channel Blocker 7 (10)